Jim Cramer Talked About These 15 Stocks

Page 14 of 14

1. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders: 60

Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer talked about. A caller asked if investors should take advantage of the recent dip and buy the stock. In response, Cramer said:

“They’re very poorly run. I don’t know this new CEO, but they are incredibly poorly run, and I’m not going to bet that they suddenly are going to change stripes… They take my breath away about how bad, how poorly they are.”

Novo Nordisk A/S (NYSE:NVO) develops and markets pharmaceutical products focused on diabetes, obesity, cardiovascular disease, and rare disorders. While discussing the stock in a July episode, Cramer said that it is not for him. He commented:

“I want you to know I don’t want Novo Nordisk… and the reason that is because if there’s going to be talk about tariffs on foreign drugs versus Eli Lilly, Novo is going to have an even less of an edge on this thing. So I say Novo, we don’t need the bottom finish. It’s not for me.”

While we acknowledge the potential of Novo Nordisk A/S (NYSE:NVO) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 14 of 14